A number of research firms have changed their ratings and price targets for Tactile Systems Technology (NASDAQ: TCMD):

  • 8/10/2017 – Tactile Systems Technology was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $37.00 price target on the stock. According to Zacks, “Tactile Systems Technology, Inc. is a medical technology company which develops medical devices for the treatment of chronic diseases at home. The company’s product pipeline consists of Flexitouch System(R), the Entré System and the ACTitouch System (R). Tactile Systems Technology, Inc. is headquartered in Minneapolis, Minnesota. “
  • 8/8/2017 – Tactile Systems Technology had its price target raised by analysts at Piper Jaffray Companies from $30.00 to $36.00. They now have an “overweight” rating on the stock.
  • 8/8/2017 – Tactile Systems Technology had its “buy” rating reaffirmed by analysts at Canaccord Genuity. They now have a $37.00 price target on the stock, up previously from $28.00.
  • 7/28/2017 – Tactile Systems Technology was upgraded by analysts at ValuEngine from a “sell” rating to a “hold” rating.
  • 7/13/2017 – Tactile Systems Technology was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Tactile Systems Technology, Inc. is a medical technology company which develops medical devices for the treatment of chronic diseases at home. The company’s product pipeline consists of Flexitouch System(R), the Entré System and the ACTitouch System (R). Tactile Systems Technology, Inc. is headquartered in Minneapolis, Minnesota. “
  • 6/27/2017 – Tactile Systems Technology was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Tactile Systems Technology, Inc. is a medical technology company which develops medical devices for the treatment of chronic diseases at home. The company’s product pipeline consists of Flexitouch System(R), the Entré System and the ACTitouch System (R). Tactile Systems Technology, Inc. is headquartered in Minneapolis, Minnesota. “
  • 6/20/2017 – Tactile Systems Technology was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $29.00 price target on the stock. According to Zacks, “Tactile Systems Technology, Inc. is a medical technology company which develops medical devices for the treatment of chronic diseases at home. The company’s product pipeline consists of Flexitouch System(R), the Entré System and the ACTitouch System (R). Tactile Systems Technology, Inc. is headquartered in Minneapolis, Minnesota. “
  • 6/17/2017 – Tactile Systems Technology was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Tactile Systems Technology, Inc. is a medical technology company which develops medical devices for the treatment of chronic diseases at home. The company’s product pipeline consists of Flexitouch System(R), the Entré System and the ACTitouch System (R). Tactile Systems Technology, Inc. is headquartered in Minneapolis, Minnesota. “

Shares of Tactile Systems Technology Inc (NASDAQ TCMD) opened at 33.94 on Wednesday. The stock’s 50 day moving average is $29.94 and its 200 day moving average is $22.64. The stock has a market cap of $596.87 million and a price-to-earnings ratio of 128.56. Tactile Systems Technology Inc has a 52 week low of $12.70 and a 52 week high of $35.79.

Tactile Systems Technology (NASDAQ:TCMD) last issued its quarterly earnings results on Monday, August 7th. The company reported $0.04 EPS for the quarter, topping the consensus estimate of $0.01 by $0.03. Tactile Systems Technology had a net margin of 14.42% and a return on equity of 24.23%. The company had revenue of $26.30 million during the quarter, compared to analyst estimates of $23.88 million. During the same quarter in the previous year, the firm earned $0.04 EPS. The firm’s revenue was up 33.5% compared to the same quarter last year. On average, equities analysts forecast that Tactile Systems Technology Inc will post $0.28 EPS for the current year.

In other Tactile Systems Technology news, CEO Gerald R. Mattys sold 20,000 shares of Tactile Systems Technology stock in a transaction on Friday, May 19th. The shares were sold at an average price of $24.00, for a total transaction of $480,000.00. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Mary E. Anderson sold 13,586 shares of Tactile Systems Technology stock in a transaction on Wednesday, May 24th. The stock was sold at an average price of $23.72, for a total transaction of $322,259.92. Following the sale, the vice president now directly owns 64,041 shares in the company, valued at approximately $1,519,052.52. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 1,009,807 shares of company stock worth $26,395,094. 49.90% of the stock is currently owned by corporate insiders.

Tactile Systems Technology, Inc is a medical technology company that develops and provides medical devices for the treatment of chronic diseases at home. The Company is a manufacturer and distributor of the Flexitouch and Entre Systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device used to treat venous leg ulcers and chronic venous insufficiency.

Receive News & Ratings for Tactile Systems Technology Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology Inc and related companies with MarketBeat.com's FREE daily email newsletter.